VIVUS, Inc. (NASDAQ: VVUS) will be giving a presentation at JP Morgan's 28th Annual Healthcare Conference. The company's CEO, Leland Wilson, will be hosting the company's presentation. Leland is scheduled to give a presentation on January 11th at 8:00am (PST). The event is taking place in San Francisco at the Westin St. Francis Hotel. The presentation will be webcast both live and for replay over the company's website.
Xplosive Stocks, an online financial publication, provides investors timely stock market information.
Sign Up Today for our Free Stock Newsletter
About VIVUS
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa®, has completed phase 3 clinical trials for the treatment of obesity and an NDA was submitted to the FDA in December 2009.
Sign up for the free Xplosive Stocks newsletter. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Xplosive Stocks can sign up for free by visiting our website.
About Us
Xplosive Stock is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We focus on Xplosive Stocks and track small cap companies that are on the brink of a financial breakout. To feature a company on our website please contact us at the email listed below.
Please click here to read the full disclaimer.
